Label: ANTICOAGULANT SODIUM CITRATE- trisodium citrate dihydrate solution
- NDC Code(s): 0338-9669-01
- Packager: Baxter Healthcare Corporation
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: New Drug Application
Drug Label Information
Updated April 2, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
INDICATIONS AND USAGE Anticoagulant Sodium Citrate 4% w/v Solution, USP is intended for use only with automated apheresis devices.
-
ADMINISTRATION The pouch is a moisture barrier. Do not remove from pouch until ready to use. Do not use unless solution is clear and no leaks detected. Do not use unless port protector is in place.
-
DOSAGE FORMS AND STRENGTHS Anticoagulant Sodium Citrate 4% w/v Solution, USP in the 250 mL single dose container is a sterile solution that contains 4g Sodium Citrate Dihydrate, USP per 100 mL, pH adjusted with citric ...
-
PRECAUTIONS Not for direct intravenous infusion.
-
HOW SUPPLIED Anticoagulant Sodium Citrate 4% w/v Solution, USP is a clear solution supplied in sterile and nonpyrogenic PVC bags per carton. Storage and Handling - Store at room temperature (25C/77F). Avoid ...
-
PACKAGE/LABEL PRINCIPAL DISPLAY PANEL LOT - EXP - 2B7867 - NDC 0338-9669-01 - Anticoagulant - Sodium Citrate - 4% w/v - Solution USP - Rx only - 250 mL EACH 100 mL CONTAINS 4 g SODIUM - CITRATE (DIHYDRATE) USP - pH ADJUSTED WITH CITRIC ACID ...
-
INGREDIENTS AND APPEARANCEProduct Information